BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8303315)

  • 21. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Historical aspects of treatment of patients with cirrhosis and ascites.
    Runyon BA
    Semin Liver Dis; 1997; 17(3):163-73. PubMed ID: 9308122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of ascites in liver cirrhosis].
    Beaugrand M
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T25-8. PubMed ID: 8045356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of surgical therapy in the treatment of refractory ascites].
    Pisani Ceretti A; Intra M; Borzio M; Santambrogio R; Opocher E; Ballarini C; Cordovana A; Motta R; Spina GP
    Minerva Chir; 1997 Nov; 52(11):1339-48. PubMed ID: 9489332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE; Fasakin Y; El-Serag HB
    Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of ascites in liver diseases].
    Gerbes AL; Paumgartner G
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1549-54. PubMed ID: 7956790
    [No Abstract]   [Full Text] [Related]  

  • 29. [How I treat ... ascites].
    Gielen S; Delwaide J; Detry O; Belaiche J;
    Rev Med Liege; 2001 Dec; 56(12):809-15. PubMed ID: 11820032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy in hepatic ascites].
    Knoblauch M
    Praxis (Bern 1994); 1995 May; 84(19):561-3. PubMed ID: 7792465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.
    Arroyo V
    Acta Gastroenterol Belg; 1990; 53(2):249-55. PubMed ID: 2267904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of ascites: old and new remedies.
    Inturri P; Graziotto A; Rossaro L
    Dig Dis; 1996; 14(3):145-56. PubMed ID: 8861522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment options for cirrhotic ascites.
    Wilkinson SP
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):1-3. PubMed ID: 9565461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of cirrhotic ascites.
    Alaniz C
    Clin Pharm; 1989 Sep; 8(9):645-54. PubMed ID: 2676316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paracentesis in the treatment of ascites in cirrhotic patients].
    Uriz Otano J; Sort P; Arroyo V
    Gastroenterol Hepatol; 1999; 22(7):356-63. PubMed ID: 10535210
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
    Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effective methods of treating ascites.
    Tabibian N
    Am Fam Physician; 1988 May; 37(5):141-6. PubMed ID: 3129923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.